Click for best price
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share 2022
This report contains market size and forecasts of Cancer Immunotherapy Drug Discovery Outsourcing in Global, including the following market information:
The global Cancer Immunotherapy Drug Discovery Outsourcing market was valued at 1027.7 million in 2021 and is projected to reach US$ 2031 million by 2028, at a CAGR of 10.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Drug Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy Drug Discovery Outsourcing include Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co. and Horizon Discovery Group PLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cancer Immunotherapy Drug Discovery Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Type, 2021 (%)
- By Drug Type
- By Cancer Type
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, by Application, 2021 (%)
- Lung
- Breast
- Colorectal
- Melanoma
- Prostate
- Head and Neck
- Ovarian
- Pancreatic
Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cancer Immunotherapy Drug Discovery Outsourcing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aquila BioMedical
- BPS Bioscience, Inc.
- Celentyx Ltd
- Crown Bioscience, Inc.
- DiscoverX Corporation
- Explicyte
- Genscript Biotech Corporation
- HD Biosciences Co.
- Horizon Discovery Group PLC
- ImmunXperts SA
- Molecular Imaging, Inc.
- Promega Corporation,Personalis, Inc.
- STC Biologics
| Report Attributes |
Report Details |
| Report Title |
Cancer Immunotherapy Drug Discovery Outsourcing Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Immunotherapy Drug Discovery Outsourcing Overall Market Size
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size: 2021 VS 2028
2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market
3.2 Top Global Cancer Immunotherapy Drug Discovery Outsourcing Companies Ranked by Revenue
3.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Immunotherapy Drug Discovery Outsourcing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Immunotherapy Drug Discovery Outsourcing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Immunotherapy Drug Discovery Outsourcing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Markets, 2021 & 2028
By Drug Type
By Cancer Type
4.2 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
4.2.1 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2022
4.2.2 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2023-2028
4.2.3 By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2021 & 2028
5.1.2 Lung
5.1.3 Breast
5.1.4 Colorectal
5.1.5 Melanoma
5.1.6 Prostate
5.1.7 Head and Neck
5.1.8 Ovarian
5.1.9 Pancreatic
5.2 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
5.2.1 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2022
5.2.2 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2023-2028
5.2.3 By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2021 & 2028
6.2 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue & Forecasts
6.2.1 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2022
6.2.2 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2023-2028
6.2.3 By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028
6.3.2 US Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.3.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.3.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028
6.4.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.3 France Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.4 U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.5 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.6 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.4.8 Benelux Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028
6.5.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.5.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.5.4 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.5.6 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028
6.6.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.6.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028
6.7.2 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.7.3 Israel Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
6.7.5 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size, 2017-2028
7 Players Profiles
7.1 Aquila BioMedical
7.1.1 Aquila BioMedical Corporate Summary
7.1.2 Aquila BioMedical Business Overview
7.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.1.4 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.1.5 Aquila BioMedical Key News
7.2 BPS Bioscience, Inc.
7.2.1 BPS Bioscience, Inc. Corporate Summary
7.2.2 BPS Bioscience, Inc. Business Overview
7.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.2.4 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.2.5 BPS Bioscience, Inc. Key News
7.3 Celentyx Ltd
7.3.1 Celentyx Ltd Corporate Summary
7.3.2 Celentyx Ltd Business Overview
7.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.3.4 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.3.5 Celentyx Ltd Key News
7.4 Crown Bioscience, Inc.
7.4.1 Crown Bioscience, Inc. Corporate Summary
7.4.2 Crown Bioscience, Inc. Business Overview
7.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.4.4 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.4.5 Crown Bioscience, Inc. Key News
7.5 DiscoverX Corporation
7.5.1 DiscoverX Corporation Corporate Summary
7.5.2 DiscoverX Corporation Business Overview
7.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.5.4 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.5.5 DiscoverX Corporation Key News
7.6 Explicyte
7.6.1 Explicyte Corporate Summary
7.6.2 Explicyte Business Overview
7.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.6.4 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.6.5 Explicyte Key News
7.7 Genscript Biotech Corporation
7.7.1 Genscript Biotech Corporation Corporate Summary
7.7.2 Genscript Biotech Corporation Business Overview
7.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.7.4 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.7.5 Genscript Biotech Corporation Key News
7.8 HD Biosciences Co.
7.8.1 HD Biosciences Co. Corporate Summary
7.8.2 HD Biosciences Co. Business Overview
7.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.8.4 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.8.5 HD Biosciences Co. Key News
7.9 Horizon Discovery Group PLC
7.9.1 Horizon Discovery Group PLC Corporate Summary
7.9.2 Horizon Discovery Group PLC Business Overview
7.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.9.4 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.9.5 Horizon Discovery Group PLC Key News
7.10 ImmunXperts SA
7.10.1 ImmunXperts SA Corporate Summary
7.10.2 ImmunXperts SA Business Overview
7.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.10.4 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.10.5 ImmunXperts SA Key News
7.11 Molecular Imaging, Inc.
7.11.1 Molecular Imaging, Inc. Corporate Summary
7.11.2 Molecular Imaging, Inc. Business Overview
7.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.11.4 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.11.5 Molecular Imaging, Inc. Key News
7.12 Promega Corporation,Personalis, Inc.
7.12.1 Promega Corporation,Personalis, Inc. Corporate Summary
7.12.2 Promega Corporation,Personalis, Inc. Business Overview
7.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.12.4 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.12.5 Promega Corporation,Personalis, Inc. Key News
7.13 STC Biologics
7.13.1 STC Biologics Corporate Summary
7.13.2 STC Biologics Business Overview
7.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Major Product Offerings
7.13.4 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global Market (2017-2022)
7.13.5 STC Biologics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunities & Trends in Global Market
Table 2. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers in Global Market
Table 3. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints in Global Market
Table 4. Key Players of Cancer Immunotherapy Drug Discovery Outsourcing in Global Market
Table 5. Top Cancer Immunotherapy Drug Discovery Outsourcing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Immunotherapy Drug Discovery Outsourcing Product Type
Table 9. List of Global Tier 1 Cancer Immunotherapy Drug Discovery Outsourcing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Immunotherapy Drug Discovery Outsourcing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Immunotherapy Drug Discovery Outsourcing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2023-2028
Table 30. Aquila BioMedical Corporate Summary
Table 31. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 32. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 33. BPS Bioscience, Inc. Corporate Summary
Table 34. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 35. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 36. Celentyx Ltd Corporate Summary
Table 37. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 38. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 39. Crown Bioscience, Inc. Corporate Summary
Table 40. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 41. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 42. DiscoverX Corporation Corporate Summary
Table 43. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 44. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 45. Explicyte Corporate Summary
Table 46. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 47. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 48. Genscript Biotech Corporation Corporate Summary
Table 49. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 50. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 51. HD Biosciences Co. Corporate Summary
Table 52. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 53. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 54. Horizon Discovery Group PLC Corporate Summary
Table 55. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 56. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 57. ImmunXperts SA Corporate Summary
Table 58. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 59. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 60. Molecular Imaging, Inc. Corporate Summary
Table 61. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 62. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 63. Promega Corporation,Personalis, Inc. Corporate Summary
Table 64. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 65. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
Table 66. STC Biologics Corporate Summary
Table 67. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product Offerings
Table 68. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Immunotherapy Drug Discovery Outsourcing Segment by Type in 2021
Figure 2. Cancer Immunotherapy Drug Discovery Outsourcing Segment by Application in 2021
Figure 3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2021
Figure 8. By Type - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 12. US Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 24. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue, (US$, Mn), 2017-2028
Figure 37. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
